Literature DB >> 19590742

Behavioral Comorbidities in Rheumatoid Arthritis: A Psychoneuroimmunological Perspective.

Michael R Irwin1, Mary Davis, Alex Zautra.   

Abstract

Entities:  

Year:  2008        PMID: 19590742      PMCID: PMC2707019     

Source DB:  PubMed          Journal:  Psychiatr Times        ISSN: 0893-2905


× No keyword cloud information.
  43 in total

Review 1.  Behavioral and motivational effects of immune-system activation.

Authors:  Susan J Larson
Journal:  J Gen Psychol       Date:  2002-10

2.  Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation.

Authors:  Michael R Irwin; Minge Wang; Capella O Campomayor; Alicia Collado-Hidalgo; Steve Cole
Journal:  Arch Intern Med       Date:  2006-09-18

3.  Coping with rheumatoid arthritis pain in daily life: within-person analyses reveal hidden vulnerability for the formerly depressed.

Authors:  Tamlin S Conner; Howard Tennen; Alex J Zautra; Glenn Affleck; Stephen Armeli; Judith Fifield
Journal:  Pain       Date:  2006-08-14       Impact factor: 6.961

4.  Mirthful laughter differentially affects serum pro- and anti-inflammatory cytokine levels depending on the level of disease activity in patients with rheumatoid arthritis.

Authors:  T Matsuzaki; A Nakajima; S Ishigami; M Tanno; S Yoshino
Journal:  Rheumatology (Oxford)       Date:  2005-11-30       Impact factor: 7.580

Review 5.  Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition.

Authors:  S F Maier; L R Watkins
Journal:  Psychol Rev       Date:  1998-01       Impact factor: 8.247

6.  Sleep and pain.

Authors:  Harvey Moldofsky
Journal:  Sleep Med Rev       Date:  2001-10       Impact factor: 11.609

7.  Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry.

Authors:  Suzanne C Segerstrom; Gregory E Miller
Journal:  Psychol Bull       Date:  2004-07       Impact factor: 17.737

8.  Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications.

Authors:  Alexandros N Vgontzas; Manolis Zoumakis; Edward O Bixler; Hung-Mo Lin; Paolo Prolo; Antonio Vela-Bueno; Anthony Kales; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

9.  Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue.

Authors:  Mary C Davis; Alex J Zautra; Jarred Younger; Sarosh J Motivala; Jeanne Attrep; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2007-08-15       Impact factor: 7.217

10.  Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African American alcoholics.

Authors:  Michael Irwin; Gina Rinetti; Laura Redwine; Sarosh Motivala; Jeff Dang; Cindy Ehlers
Journal:  Brain Behav Immun       Date:  2004-07       Impact factor: 7.217

View more
  4 in total

Review 1.  Healthcare burden of depression in adults with arthritis.

Authors:  Usha Sambamoorthi; Drishti Shah; Xiaohui Zhao
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2017-01-20       Impact factor: 2.217

2.  Association of Depression With Risk of Incident Systemic Lupus Erythematosus in Women Assessed Across 2 Decades.

Authors:  Andrea L Roberts; Laura D Kubzansky; Susan Malspeis; Candace H Feldman; Karen H Costenbader
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

3.  Bidirectional associations between rheumatoid arthritis and depression: a nationwide longitudinal study.

Authors:  Ming-Chi Lu; How-Ran Guo; Miao-Chiu Lin; Hanoch Livneh; Ning-Sheng Lai; Tzung-Yi Tsai
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

4.  Does depression increase the risk of stroke in patients with rheumatoid arthritis? A population-based cohort study.

Authors:  Tzung-Yi Tsai; Ming-Chi Lu; Hanoch Livneh; Shan-Yun Chiu; Ning-Sheng Lai; How-Ran Guo
Journal:  BMJ Open       Date:  2017-06-22       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.